Magda F. Ismail

Cairo, C 11754, Egypt

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications

Review on drug repositioning of some FDA-approved drugs for treatment of cancer/microbial diseases.

Review on drug repositioning of some FDA-approved drugs for treatment of cancer/microbial diseases.

Journal: RSC advances
Published: April 21, 2026

Novel niclosamide-derived Schiff bases as a dual-targeted anticancer agents.

Novel niclosamide-derived Schiff bases as a dual-targeted anticancer agents.

Journal: Scientific reports
Published: September 10, 2025

Predicting decay pathways in superheavy nuclei: theoretical insights into α and cluster radioactivity.

Predicting decay pathways in superheavy nuclei: theoretical insights into α and cluster radioactivity.

Journal: Scientific reports
Published: August 01, 2025

Combating oxi-inflamm-aging: Passerini adducts tethered with 1,2,3-triazoles for enhanced antioxidant defense and 5-LOX inhibition.

Combating oxi-inflamm-aging: Passerini adducts tethered with 1,2,3-triazoles for enhanced antioxidant defense and 5-LOX inhibition.

Journal: RSC medicinal chemistry
Published: December 11, 2024

Correction: Reinvestigation of Passerini and Ugi scaffolds as multistep apoptotic inducers via dual modulation of caspase 3/7 and P53-MDM2 signaling for halting breast cancer.

Correction: Reinvestigation of Passerini and Ugi scaffolds as multistep apoptotic inducers via dual modulation of caspase 3/7 and P53-MDM2 signaling for halting breast cancer.

Journal: RSC advances
Published: November 29, 2024

New molecular hybrids integrated with quinoxaline and pyrazole structural motifs: VGFR2 inhibitors and apoptosis inducers.

New molecular hybrids integrated with quinoxaline and pyrazole structural motifs: VGFR2 inhibitors and apoptosis inducers.

Journal: Bioorganic chemistry
Published: October 14, 2024

Preparation and kinetic studies of a new antibacterial sodium alginate gelatin hydrogel composite.

Preparation and kinetic studies of a new antibacterial sodium alginate gelatin hydrogel composite.

Journal: Scientific reports
Published: August 17, 2024

Correction: Targeting EGFR/PI3K/AKT/mTOR signaling in lung and colon cancers: synthesis, antitumor evaluation of new 1,2,4-oxdiazoles tethered 1,2,3-triazoles.

Correction: Targeting EGFR/PI3K/AKT/mTOR signaling in lung and colon cancers: synthesis, antitumor evaluation of new 1,2,4-oxdiazoles tethered 1,2,3-triazoles.

Journal: RSC advances
Published: May 29, 2024

Targeting EGFR/PI3K/AKT/mTOR signaling in lung and colon cancers: synthesis, antitumor evaluation of new 1,2,4-oxdiazoles tethered 1,2,3-triazoles.

Targeting EGFR/PI3K/AKT/mTOR signaling in lung and colon cancers: synthesis, antitumor evaluation of new 1,2,4-oxdiazoles tethered 1,2,3-triazoles.

Journal: RSC advances
Published: March 23, 2024

Pharmacological investigation of new niclosamide-based isatin hybrids as antiproliferative, antioxidant, and apoptosis inducers.

Pharmacological investigation of new niclosamide-based isatin hybrids as antiproliferative, antioxidant, and apoptosis inducers.

Journal: Scientific reports
Published: March 07, 2024

Novel quinoxaline-3-propanamides as VGFR-2 inhibitors and apoptosis inducers.

Novel quinoxaline-3-propanamides as VGFR-2 inhibitors and apoptosis inducers.

Journal: RSC advances
Published: July 26, 2023

Reinvestigation of Passerini and Ugi scaffolds as multistep apoptotic inducers via dual modulation of caspase 3/7 and P53-MDM2 signaling for halting breast cancer.

Reinvestigation of Passerini and Ugi scaffolds as multistep apoptotic inducers via dual modulation of caspase 3/7 and P53-MDM2 signaling for halting breast cancer.

Journal: RSC advances
Published: June 15, 2023
Showing 1-12 of 30

Last Updated: 09/26/2026